On Wednesday, Shares of Mastercard Inc (NYSE:MA), lost -3.13% to $89.99.
Technology now touches nearly every retail transaction, creating a vastly different shopping experience for retailers and consumers alike, according to a report released by MasterCard. Eight out of ten global shoppers’ purchase decisions are now informed by a digital device, with consumers saying they are smarter shoppers and getting more value than before. However, though in-store sales still account for more than nine-tenths of all retail spending, the result is a more focused in-store shopper buying from a narrower list of unique stores than in years past.
“Getting smart about smart shoppers is paramount to a retailer’s success, yet shoppers consistently report they’re frustrated that retailers don’t get it,” says Mathieu Loury, senior vice president of Merchant Solutions for MasterCard Advisors, the professional services arm of MasterCard. “The good news is that the solutions exist to both analyze and answer these expectations—meeting your omnishoppers every step of their empowered journey, and creating an ecosystem that propels them forward.” The MasterCard Retail CMO’s Guide to the Omnishopper combines survey data from thousands of shoppers around the globe with transaction-based insights from MasterCard.
MasterCard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. The company facilitates the processing of payment transactions, counting authorization, clearing, and settlement, in addition to delivers related products and services.
Shares of Abbott Laboratories (NYSE:ABT), declined -1.84% to $43.23, during its last trading session.
Abbott Laboratories declared that it has accomplished its acquisition of Tendyne Holdings, Inc., a private medical device company focused on developing minimally invasive mitral valve replacement therapies. Abbott attained the equity of Tendyne that it did not already own for $225 million upfront, resulting in a total transaction value of $250 million, and potential future payments tied to regulatory milestones.
“The Tendyne acquisition broadens Abbott’s foundation as a leader in treatments for mitral valve disease, which is highly complex and requires multiple treatment options,” said John M. Capek, Ph.D., executive vice president, Ventures, Abbott. “Our aim is to provide effective, less invasive valve treatment technologies to treat people based on their specific anatomy and health situation.”
Tendyne’s Bioprosthetic Mitral Valve System is designed to be implanted in a beating heart, without the need for open heart surgery, which would be a new treatment option for mitral valve replacement. It is an investigational device and not presently available for sale. The U.S. Food and Drug Administration has given approval for a feasibility clinical trial to provide data about the device’s safety and effectiveness. The trial has begun enrolling patients, and there are plans to start enrollment next year in a clinical trial to support CE Mark in Europe.
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon.
Finally, Yandex NV (NASDAQ:YNDX), ended its last trade with -1.56% loss, and closed at $11.33.
Yandex.Direct, Yandex’s pay-per-click advertising platform, is changing its auction system and introducing new ranking rules for paid search results. Starting tomorrow, instead of a generalized second-price auction (GSP), Yandex.Direct will be using a Vickery-Clarke-Groves (VGC) auction to serve ads in the premium positions on its search engine results page (SERP) and the SERPs of websites in the Yandex Advertising Network. Ads competing for the ad block on the SERPs will be selected based on their quality, in addition to advertisers’ bids. These changes are aimed at providing Yandex’s advertising clients with maximum traffic at an optimal price, while serving the ads that are most relevant to our users.
“Changes in Yandex.Direct respond to changes in the advertising market. Cost of traffic and return on investment have become more important than having ads in premium positions. The second-price auction doesn’t allow advertisers to fully benefit from running their ads in top positions. They tend to prefer paying less for lower positions at the expense of additional clicks. Now, we’re changing the rules so that attracting more traffic will become more efficient for our advertisers,” says Eugene Lomize, head of monetization at Yandex.
Yandex N.V. operates an Internet search engine in Russia and internationally. The company offers search, location-based, personalized, and mobile services that enable users to find information, and communicate and connect over the Internet from desktops and mobile devices; and localized homepages for specific geographic markets.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
